{"transactions":[{"id":2394332,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":130400,"kind":"person","name":"Keane Raymond T","position":1,"cik":"0001448434","reported_name":"Keane Raymond T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-02-15T16:48:52.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares underlying the option vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":45000,"derivative":{"exercise_price":13.6,"expiration_date":"2032-02-10","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0000899243-22-006421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1448434/000089924322006421/doc4.xml","form_type":"4"}},{"id":2394331,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":130400,"kind":"person","name":"Keane Raymond T","position":1,"cik":"0001448434","reported_name":"Keane Raymond T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Common Stock","published_at":"2022-02-15T16:48:52.000Z","date":"2022-02-11","kind":"grant","acquired":true,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares underlying the restricted stock unit vest over four years, with one forty-eighty (1/48th) of the shares vesting in equal monthly installments until the fourth anniversary of the grant date."}],"balance_after":24124,"source":{"system":"sec-edgar","filing":"0000899243-22-006421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448434/000089924322006421/doc4.xml","form_type":"4"}},{"id":2910879,"issuer":{"id":4766,"kind":"organization","name":"Cullinan Therapeutics, Inc.","symbol":"CGEM"},"owners":[{"id":130400,"kind":"person","name":"Keane Raymond T","position":1,"cik":"0001448434","reported_name":"Keane Raymond T","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Legal Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T17:31:52.000Z","date":"2021-01-07","kind":"grant","acquired":true,"shares":249998,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option represents a right to purchase a total of 249,998 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on January 7, 2022, with the remaining shares vesting in equal monthly installments over the following three years (36 months), subject to the reporting person's continued employment with the Issuer."}],"balance_after":249998,"derivative":{"exercise_price":21,"expiration_date":"2031-01-06","underlying":"Common Stock","underlying_shares":249998},"source":{"system":"sec-edgar","filing":"0000899243-21-001359","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1448434/000089924321001359/doc4.xml","form_type":"4"}}]}